VRX Related Analyst Ratings

Jul 9, 2009 09:09 AM Leerink Swann Downgrades Valeant Pharmaceuticals (VRX) to Market Perform; Adjusts Q2 Estimates

Jul 6, 2009 04:44 PM Piper Jaffray Initiates Coverage on Valeant Pharmaceuticals (VRX) with an Underweight; Valuation Based on Sum-of-the-Parts

Jun 9, 2009 08:00 AM Wachovia Downgrades Valeant Pharmaceuticals (VRX) to Underperform; Risk/Reward Unfavorable

May 14, 2009 09:18 AM Soleil Securities Slaps A 'Sell' Rating on Valeant Pharmaceuticals (VRX)

Mar 24, 2009 09:10 AM Leerink Swann Initiates Coverage on Valeant Pharmaceuticals (VRX) with an Outperform

Oct 28, 2008 09:17 AM Brean Murray Initiates Coverage on Valeant Pharmaceuticals (VRX) with a Sell

Oct 2, 2008 10:44 AM Matrix USA Rating Changes 10/2

Sep 23, 2008 09:11 AM Lazard Upgrades Valeant Pharma (VRX) to Hold

Aug 25, 2008 09:24 AM Matrix USA Rating Changes 8/25

May 28, 2008 10:17 AM Matrix USA Rating Changes 5/28

May 21, 2008 10:27 AM Matrix USA Rating Changes 5/21

Mar 10, 2008 10:17 AM Matrix USA Rating Changes 3/10

Feb 29, 2008 12:18 PM Matrix USA Rating Changes 2/29

Feb 29, 2008 09:23 AM Merrill Lynch Downgrades Valeant Pharmaceuticals (VRX) to Neutral

Feb 13, 2008 07:26 AM Bear Stearns Upgrades Valeant Pharmaceuticals (VRX) to Peer Perform

Dec 10, 2007 09:13 AM Matrix USA Rating Changes 12/10

Nov 15, 2007 09:16 AM Matrix USA Rating Changes 11/15

Nov 5, 2007 08:54 AM Bear Stearns downgrades Valeant Pharmaceuticals (VRX) to Underperform

Jun 6, 2007 09:12 AM Merrill Lynch Upgrades Valeant Pharmaceuticals (VRX) to Buy

Jun 1, 2007 09:19 AM Citigroup Investment Research Announces SMID Target List: Launching a New Small/Mid Cap Portfolio

Sep 13, 2006 10:00 AM Lazard Capital Downgrades Valeant Pharmaceuticals (VRX) to Hold

Jul 13, 2006 08:15 AM Friedman Billings Starts Valeant Pharmaceuticals (VRX) at Market Perform

Jun 15, 2006 09:30 AM CE Unterberg Starts Metabasis Therapeutics (MBRX) at Buy

Apr 28, 2006 07:43 AM Bear Stearns Starts Valeant Pharmaceuticals (VRX) at Peer Perform

Apr 4, 2006 07:31 AM Piper Jaffray downgrades Valeant Phama (VRX) to Market Perform

Apr 4, 2006 07:14 AM Piper Jaffray Downgrades Valeant Pharmaceuticals (VRX) to Market Perform

Mar 21, 2006 03:07 PM Piper Jaffray Comments on Valeant (VRX)

Jun 23, 2005 07:50 AM Think Equity Starts VRX at Sell